Active Research Protocols
- 02-C-0212 – Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
- 08-C-0151 – A Pilot Study of Sirolimus (Rapamycin, Rapammune[Registered Trademark]) in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014